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Background. For a majority of patients undergoing anaesthesia for general surgery, mean
arterial pressure (MAP) is only measured intermittently by arm cuff oscillometry (MAPiNIAP).
In contrast, the Nexfinw device provides continuous non-invasive measurement of MAP
(MAPcNIAP) using a finger cuff. We explored the agreement of MAPcNIAP and MAPiNIAP with
the gold standard: continuous invasive MAP measurement by placement of a radial artery
catheter (MAPinvasive).
Methods. In a total of 120 patients undergoing elective general surgeryand clinically requiring
MAPinvasive measurement, MAPiNIAP and MAPcNIAP were measured in a 30 min time
period at an arbitrary moment during surgery with stable haemodynamics. MAPiNIAP was
measured every 5 min.
Results. Data from 112 patients were analysed. Compared with MAPinvasive, modified Bland–
Altman analysis revealed a bias (SD) of 2 (9) mm Hg for MAPcNIAP and 22 (12) mm Hg for
MAPiNIAP. Percentage errors for MAPcNIAP and MAPiNIAP were 22% and 32%, respectively.
Conclusions. In a haemodynamically stable phase in patients undergoing general
anaesthesia, the agreement with invasive MAP of continuous non-invasive measurement
using a finger cuff was not inferior to the agreement of intermittent arm cuff oscillometry.
Continuous measurements using a finger cuff can interchangeably be used as an
alternative for intermittent arm cuff oscillometry in haemodynamically stable patients, with
the advantage of beat-to-beat haemodynamic monitoring.
Clinical trial registration. NCT 01362335 (clinicaltrials.gov).
Keywords: Nexfin; NIAP; non-invasive arterial pressure; volume clamp
Accepted for publication: 12 January 2014
Mean arterial pressure (MAP) monitoring, along with pulse oxi-
metric assessment of heart rate and arterial oxygen satur-
ation, is mandatory in patients undergoing surgery,
irrespective of the type of anaesthesia the patient receives.1
During major surgical procedures or in high-risk patients, con-
tinuous (invasive) arterial pressure measurement using an
indwelling arterial catheter is preferred to closely monitor
‘beat-to-beat’ changes in MAP. In addition, this method can
be regarded as the clinical ‘gold’ standard for monitoring of
MAP (MAPinvasive). However, placement of an indwelling arterial
catheter is prone to several complications.2 3 Thus, MAPinvasive
use is limited to patients in whom the advantage of continuous
MAP measurement outweighs the risk of placement of the ar-
terial catheter or when frequent arterial blood sampling is
required.
In most cases, conventional non-invasive intermittent
measurement of MAP by arm cuff oscillometry (MAPiNIAP)
with an interval of 3–5 min is considered appropriate.1 In add-
ition, it is not considered harmful (i.e. non-invasive) and easy to
perform. Nevertheless, its accuracy is dependent on appropri-
ate positioning of the patient, correct cuff positioning, and ad-
equate cuff size, and may be impaired by patient conditions
such as arrhythmia and obesity.4 5 MAPiNIAP has been validated
with the cuff placed around the upper arm; but since the upper
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arm may be inaccessible in some patients (due to wounds, frac-
tures, oedema, vascular access), cuff locations on the calf or
thigh are considered as alternative measurement sites, al-
though they decrease measurement accuracy considerably.5
On the top of decreased accuracy, MAPiNIAP does not allow con-
tinuous, ‘beat-to-beat’ monitoring of MAP as it takes time to in-
and deflate the cuff. Moreover, because cuff deflation takes
several seconds, the determined systolic and diastolic values
originate from different heartbeats and may therefore be in-
accurate in situations where there is significant pulse pressure
variation.6
The Nexfin device (Edwards Lifesciences, Irvine, CA, USA),
introduced in 2007, is based on the volume clamp method
first introduced by the Czech physiologist Jan Penaz in 1967.7
It allows continuous non-invasive arterial pressure measure-
ment (MAPcNIAP) using a photoplethysmograph and an inflat-
able cuff placed around a finger.8 Based on the input from
the photoplethysmograph, the cuff pressure is adjusted 1000
times per second to keep the arterial volume constant during
the cardiac cycle. Thus, the artery is clamped at a diameter
where the transmural pressure is zero, and therefore the cuff
pressure is equal to the arterial pressure. This ‘volume clamp-
ing’ allows measurement of an arterial pressure waveform.
Finally, brachial arterial pressure is reconstructed from finger
arterial pressure and displayed.9
Multiple studies10 – 12 have already investigated the accur-
acy of arterial pressure measurement by this device and com-
pared it with invasively obtained measurements with various
results. Yet, the vast majority of patients undergoing surgery
is monitored solely using intermittent non-invasive measure-
ments, and therefore, it is of interest whether MAPcNIAP would
be a valuable adjunct or could ultimately replace MAPiNIAP in
the intraoperative setting.
Therefore, we explored in the current study in patients under
general anaesthesia, the agreement of both MAPcNIAP and
MAPiNIAP with the clinical standard of arterial pressure mea-
surement: MAPinvasive measurement. In addition, we analysed
whether the side of the measurement (i.e. contra- or ipsilateral
to invasive measurement) of the MAPcNIAP finger cuff affected
its accuracy.
Methods
This observational study was approved by the local medical
ethics committee (METc 2011.052, University Medical Center
Groningen, The Netherlands) and was registered at clinical-
trials.gov (NCT: 01362335).
A total of 120 patients, undergoing elective abdominal,
neurosurgical, oncological, and vascular surgery under
general anaesthesia and for which placement of a radial
artery catheter was required on clinical grounds, were included
(Fig. 1). Measurements took place at an arbitrary moment of
stable haemodynamic conditions during surgery with a total
measurement period of 30 min. At least 24 h after the oper-
ation, written informed consent was obtained for analysis of
the recorded data and patients were included for data analysis.
In all patients, anaesthesia was induced with propofol and
sufentanil or remifentanil. Anaesthesia was maintained with
propofol or sevoflurane, in combination with either sufentanil
or remifentanil, as clinically required.
Before data recording, a radial artery was cannulated using
a 20 G catheter and connected with a disposable pressure
transducer (Truwave PX-600F, Edwards Lifesciences LLC).
MAPiNIAP was measured using cuff oscillometry at the upper
arm according to routine clinical practice with the cuff size
adapted to body weight and posture, as recommended by
the manufacturer. The MAPiNIAP measurement interval was
set at 5 min.
The Nexfin cuff was placed at the intermediate phalanx,
ipsi- or contralateral to the radial artery catheter, at the most
accessible side.
To correct for hydrostatic pressure differences between the
finger and the heart, the heart reference system (HRSTM) is pro-
vided with the Nexfin device. Both the HRSTM and the arterial
pressure transducer were located at the level of the right
atrium.
MAPinvasive and MAPiNIAP datawere recorded at a 1 s and 5 min
interval, respectively, using RugLoop II data-manager software
(Demed, Temse, Belgium), connected to the anaesthesia
monitor (Philips MP70; Philips, Eindhoven, The Netherlands).
MAPcNIAP and other haemodynamic data (heart rate, cardiac
index, systemic vascular resistance index, dP/dT ) were recorded
in a beat-to-beat fashion on the Nexfin monitor. Values of
MAPinvasive, MAPiNIAP, and MAPcNIAP were imported into Microsoft
Excel 2010w (Microsoft, Redmond, WA, USA) and synchronized.
After graphical representation of these values, a visual inspec-
tion was performed to correct for obvious atypical values
caused by artifacts (mostly resulting from blood sampling and
iNIAP cuff inflation).
Statistical analysis
All statistics were performed using Microsoft Excel 2010w and
PASW Statistics 18 (SPSS Inc., Chicago, IL, USA). A 30 s
running median with 1 s steps was calculated for MAPinvasive
and MAPcNIAP. The normality of continuous variables was
assessed using the Kolmogorov–Smirnov test. Data were
expressed as mean (SD), median (range), or number of patients
(%). The distribution (median, 2.5th and 97.5th percentile) of
the difference with MAPinvasive (either MAPcNIAP or MAPiNIAP
minus MAPinvasive) was plotted for the 30 min time period.
The Mann–Whitney U-test was performed to test whether
the difference in the bias of both methods was significantly dif-
ferent. A modified Bland–Altman analysis for repeated mea-
surements13 – 15 was performed for comparison of all data
points of MAPcNIAP with MAPinvasive and of MAPiNIAP with
MAPinvasive at a 5 min time interval. In a case where cuff infla-
tion influenced continuous measurements, these variables
were determined just before inflation of the cuff and correlated
with the subsequent MAPiNIAP value. Here, the bias (SD) is calcu-
lated together with the limits of agreement [LOA¼bias (1.96
SD)]. As a measure of precision,16 coefficients of error (CE)
were calculated as the SD of the bias divided by the mean of
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measurements. Subsequently, percentage errors for MAPcNIAP
and MAPiNIAP compared with MAPinvasive were calculated as:
2.0×CE×100; here CE is from either MAPcNIAP or MAPiNIAP
bias.17
Currently, two guidelines apply to validation of arterial pres-
sure measurement by the Nexfin: one from the European
Working Group for the Validation of Blood Pressure Measuring
Devices (ESH criteria) and one from the Association for the
Advancement of Medical Instrumentation (AAMI).18 19 The
requirements for validation by the ESH criteria are summarized
in the legend of Table 1. Furthermore, AAMI criteria consider a
device acceptable if its estimated probability of tolerable error
is at least 85%, suggesting that a predefined estimated sample
mean error of 5 mm Hg should have a concomitant standard
deviation below 8 mm Hg. We used this criterion to test for
non-inferiority. Sample size calculation for our study was
based on the AAMI criteria and was calculated in order to
detect a mean difference of 5 mm Hg. For an estimated SD of
MAP values of 9 mm Hg, a power of 98% and an a-error of
0.05, at least 106 patients should be included. Therefore, we
included 120 patients in total. Statistical significance was
assumed if P,0.05.
Results
A total of 120 patients were included in this study (Fig. 1). Eight
patients were excluded from data analysis because of unwill-
ingness or inability to sign informed consent (n¼7) or technical
reasons (n¼1). Of the 112 patients analysed in total, two data
sets could not be used for the comparison of MAPcNIAP with
MAPinvasive and 11 data sets could not be used for the compari-
son of MAPiNIAP with MAPinvasive, all because of technical diffi-
culties with recording MAPcNIAP or MAPiNIAP, respectively.
Characteristics of the studied patients (n¼112) were normally
Table 1 Requirements for arterial pressure measurement
validation as set by the European Working Group for the Validation
of Blood Pressure Measuring Devices (ESH criteria). Shown is the
required minimal percentage of MAP measurements being either
very accurate, slightly inaccurate, or inaccurate. In order to
determine whether a device passes the ESH criteria, either two of
three minimal accuracy requirements (step 1) or all three minimal











Pass all three 65 81 93









Excluded from data analysis:
- Unwilling to sign informed consent (n=4)
- Unable to sign informed consent (n=3)
- Technical problems MAPinvasive registration (n=1)
Fig 1 Consort flow diagram.
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distributed and are shown together with the main haemo-
dynamic variables in Table 2.
Figure 2 shows the individual differences with MAPinvasive
values of MAPcNIAP (Fig. 2A) and MAPiNIAP measurements
(Fig. 2B) for the 30 min measurement period of all patients
together with its median and concomitant 2.5th and 97.5th
percentile.
The median difference (2.5th/97.5th percentile) of MAPcNIAP
at the start of measurements was 1 (213/8) mm Hg and was
3 (28/11) mm Hg after 30 min. The median difference of
MAPiNIAP was 22 (218/14) mm Hg at the start of measure-
ments and was 22 (218/8) mm Hg after 30 min. For all data
points, the bias of MAPcNIAP was significantly different from
that of MAPiNIAP (P,0.001, Mann–Whitney U-test).
In Figure 3 and Table 3, the bias (SD) and LOAs, as derived
from the modified Bland–Altman analysis for repeated mea-
surements, are shown for the 30 min time period with a time
interval of 5 min. Also in Table 3, CE and percentage errors for
both MAPcNIAP and MAPiNIAP are shown. The original modified
Bland–Altman plot, including all available data points, is
shown in Supplementary Figure S1.
The performance of both MAPcNIAP and MAPiNIAP measure-
ment as an alternative for MAPinvasive is shown in Table 1 for
both steps of the ESH reliability criteria. Neither MAPcNIAP nor
MAPiNIAP measurements succeeded to match any of these cri-
teria. Both measurement methods also failed to meet the
AAMI criteria (Table 3).
Influence of measurement side and absolute
MAPinvasive value on MAPcNIAP bias
The Nexfinw cuff was attached to the index finger ipsilateral
to the inserted radial artery catheter in 70 patients (63%),
whereas it was attached to the contralateral side in 42 patients
(37%). The modified Bland–Altman analysis for repeated mea-
surements revealed no differences in agreement of MAPcNIAP
with MAPinvasive between both measurement sides: bias (SD)
was 2 (9) (LOA: 216/20) mm Hg for ipsilateral and 2 (8) (LOA:
214/18) mm Hg for contralateral measurements.
Figure 4 shows the influence of MAPinvasive on MAPcNIAP ac-
curacy. Values are shown for all data points (n¼765) in the
30 min measurement period with an interval of 5 min. There
was no correlation between the two variables, indicating that
MAPinvasive had no effect on the accuracy of cNIAP.
Discussion
The agreement of the Nexfin device with invasive arterial pres-
sure measurement as a gold standard has been studied in
several recent studies, with varying results. However, much
as replacement of invasive by non-invasive measurement
has important advantages, most patients undergoing anaes-
thesia are monitored in a non-invasive fashion, and may
benefit from accurate and precise continuous non-invasive
monitoring. To the best of our knowledge, this is the first
study investigating the potential benefit of the Nexfin to
monitor arterial pressure for these patients.
In the current study in patients under general anaesthesia,
the main purpose was to quantify the accuracy and precision of
continuous non-invasive MAP measurement using the Nexfin
device (MAPcNIAP) and using conventional intermittent cuff
oscillometry (MAPiNIAP), comparing both methods with the
gold standard, that is, continuous invasive measurement of
MAP (MAPinvasive). Only periods of stable haemodynamic condi-
tions were recorded and included for further analysis.
In this phase, the Nexfin-derived MAPcNIAP showed an
agreement with invasive measurements which wasnot inferior
to the agreement of automated cuff oscillometry-derived
MAPiNIAP. This suggests that this method is at least a valuable
adjunct to measure MAPand might even be used as an alterna-
tive to MAPiNIAP in patients undergoing anaesthesia. We
observed however that both MAPiNIAP and MAPcNIAP showed
some imprecision with respect to invasive MAP measurement
(MAPinvasive) and that both methods failed to meet the AAMI
criteria and the ESH criteria for arterial pressure measurement
validation.
The accuracy of Nexfin-derived MAPcNIAP measurements
has been studied in a number of previous studies10 11 12 20 – 23
and showed close correlations with MAPinvasive in patients
undergoing cardiothoracic surgery,11 and was considered reli-
able enough to replace invasive arterial pressure monitoring in
most patients.24
MAPcNIAP and MAPiNIAP accuracy have until now only been
compared in awake—non-anaesthetized—patients, and in
these studies, they were not compared with any gold standard.
Studies comparing MAPcNIAP with MAPiNIAP in supine
patients,25 in acutely ill patients at an emergency depart-
ment,24 in pregnant women for longitudinal tracking of arterial
pressure,26 or in patients during autonomic function testing27
demonstrated adequate accuracies.
We however did not investigate the relationship between
MAPcNIAP and MAPiNIAP measurements as in our opinion, it is
more relevant—in patients receiving (general) anaesthesia—
to directly compare both MAPcNIAP and MAPiNIAP measurements
Table 2 Patient characteristics and main haemodynamic
variables. Values are expressed as mean (range) for age, mean (SD)
or as n (%) for categorical variables (n¼112)
Age (yr) 59 (22–84)
Weight (kg) 83 (19)






Heart rate (beats min21) 69 (12)
MAPinvasive (mm Hg) 82 (11)
Cardiac index (litre min21 m22) 2.9 (0.7)
Systemic vascular resistance index
(dyn s21 cm25 m22)
2398 (695)
dP/dT (mm Hg s21) 624 (238)
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with the gold standard of continuous invasive MAP measure-
ment (MAPinvasive). Surprisingly, we found that bothnon-invasive
measurement methods failed to meet the AAMI criteria
because the precision—as an indication of measurement repro-
ducibility—exceeded the pre-defined precision of 8 mm Hg.
Nevertheless, MAPcNIAP values were more closely related to
MAPinvasive values than the MAPiNIAP values, which was also
true for the agreement data provided in Tables 1 and 3. While
statistically significant, the small absolute difference does not
entail a clinically significant superior accuracy. There are, up to
our knowledge, no other studies in which the accuracy of both
MAPcNIAP and MAPiNIAP measurements were compared with
MAPinvasive measurements and therefore, these findings
require confirmation in future studies, particularly in conditions
of haemodynamic instability and during vasopressor use.
A second point of major clinical importance is that while the
difference in accuracy of both non-invasive methods is small
and arguably not clinically significant, MAPcNIAP monitoring
has the obvious advantage of providing MAP measurements
both faster and in a continuous ‘beat-to-beat’ fashion.
In this view, although inevitably less accurate than
MAPinvasive, showing non-inferiority of absolute measurement
of the MAPcNIAP relative to MAPiNIAP would be sufficient to
advocate its use.
As pointed out in a recent study,28 MAPcNIAP was able to
detect significantly more periods of hypo- and hypertension
in patients undergoing surgery compared with the use of
MAPiNIAP monitoring. Additionally, the Nexfin device can also
obtain flow-based haemodynamic variables such as cardiac
output, although reports on the accuracy of these variables
are sparse. Since MAPcNIAP is acquired at the finger, and the
MAPinvasive at the radial artery, while MAPiNIAP is measured
at the brachial level, one may ask whether the reported
































































Fig 2 The evolution in individual patients of the differences with MAPinvasive of the continuous measurement of MAPcNIAP (A) and the intermittent
measurements of MAPiNIAP (B) over the 30 min period in mm Hg. Individual patients (thin pink lines) and median values (green line) are shown to-
gether with the 2.5th and 97.5th percentile (blue lines).
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consequence of the reference point. The Nexfin algorithm
however performs a waveform transformation to reconstruct
the arterial waveform and values, and therefore, MAPcNIAP
and MAPiNIAP values should be considered brachial MAP. In add-
ition, since the higher errors in MAPiNIAP consist of overestima-
tions and underestimations (Fig. 2), a difference in reference
point is an unlikely reason for the divergent accuracy.
Still, non-inferiority of MAPcNIAP compared with MAPiNIAP
does not necessarily result in improved patient outcome, but
a faster diagnosis29 implicates a significant potential for
improved patient monitoring. An additional advantage is
likely in patients where brachialmeasurements may be difficult
such as obese patients or patients with brachial injuries or dia-
lysis shunts. However, it has to be shown if the additional costs
of measuring MAPcNIAP justify the benefits of its use described
above, also in view of a recent change in the distributer of the
device.
Study limitations
All measurements were performed in patients at arbitrary
moments during general anaesthesia. The most important
limitation therefore is that during these observation periods,
no particularly considerable changes in arterial pressure oc-
curred and therefore the accuracy and precision of both
MAPcNIAP and MAPiNIAP during substantial variations in arterial
pressure cannot be answered by this study. It has been demon-
strated that the use of continuous non-invasive measurements
decreases the total time of hypotension or hypertension during
anaesthesia significantly, but the accuracy of either assess-
ments compared with a gold standard was not investigated
in that study.30
Secondly, our measurements took place in patients with
MAPinvasive at randomlyselected moments during anaesthesia.
We did not specifically analyse the influence of changes in vas-
cular tone, for example, induced by changes in temperature
or use of vasoactive drugs. This is, however, in accordance
with normal clinical practice where reliability of MAPiNIAP may
also be dependent on a variety of physiological conditions.
Although the Physiocal algorithm of the Nexfin monitor is
developed to compensate for any changes in vascular tone
due to peripheral hypothermia or other induced changes in
local perfusion, we may not exclude a decrease in accuracy
of finger-based methods in such cases. Therefore, our con-
clusions are only valid for normothermic, haemodynami-
cally stable patients not requiring (high doses of) vasoactive
medication.
It is well known that pulse oximetry becomes less accurate
in the case of hyperpigmentation, lowblood oxygen saturation,
or certain intoxications because pulse oximetry is based on dif-
ferential absorption of two distinct wavelengths. The ple-
thysmographic measurement used for the volume clamp
method, however, does not rely on such delicately distinct
wavelength absorptions (it uses one wavelength only) and is
therefore very unlikely to be less reliable in such circumstances,













































Mean (MAPcNIAP or MAPiNIAP+MAPinvasive)/2 (mm Hg)
Modified Bland–Altman analysis 
MAPiNIAP/MAPinvasive datapoint
MAPcNIAP/MAPinvasive datapoint
Fig 3 Modified Bland–Altman plot for repeated measurements of the difference between MAPinvasive and either MAPcNIAP or MAPiNIAP against the
mean of these measurements. The values given are calculated relative to the MAPinvasive. Horizontal dotted lines show the bias. Continuous hori-
zontal lines show the limits of agreement [LOA¼bias (1.96 SD)] for MAPcNIAP (blue) and MAPiNIAP (green).
Table 3 Modified Bland–Altman analysis for repeated
measurements. Shown is a comparison for all available data points
of the agreement between either MAPiNIAP (n¼692) or MAPcNIAP
(n¼758) with MAPinvasive. Shown is the bias (SD), lower and upper
LOA, the CE, and PE (n¼765)
Bias (SD) (mm Hg) LOA (mm Hg) CE (%) PE (%)
MAPcNIAP 2 (9) 215/19 11 22
MAPiNIAP 22 (12) 226/21 16 32
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Despite the reliability of MAPcNIAP compared with MAPiNIAP,
our results also show that the agreement of MAPcNIAP with
MAPinvasive is not sufficient to advocate replacing MAPinvasive
in any case. Therefore, high-risk patients undergoing major
procedures, that is, conditions where hypothermia or high
vasopressor need may occur, will still require invasive MAP
monitoring for most reliable arterial pressure monitoring and
arterial blood sampling.
Furthermore, insufflation of the MAPiNIAP cuff is known to
induce alterations in the vascular compliance due to endo-
thelial activation and vasodilation. Our previous research
demonstrates a sustained influence on distal limb physiology
for several minutes after intermittent MAPiNIAP cuff insuf-
flation.31 It is still the subject of debate whether these micro-
vascular changes are induced by ischaemia, congestion, or
other physiological phenomena, but it is conceivable that
these local changes may influence the compliance of the vas-
cular wall and therefore the accuracy of the MAPcNIAP measure-
ments. Contrarily, inter-arm anatomical differences can also
cause different arterial pressure readings.32 Therefore, we
measured MAPcNIAP either ipsilaterally and contralaterally
with regard to MAPinvasive. Since there was no blinded ran-
domization on this matter, this may have influenced our
results. However, a subanalysis comparing data received
from the ipsilateral vs contralateral side did not reveal
any significant differences. Hence, we decided to group
all data without further differentiating the side of MAPcNIAP
measurement.
Finally, all analyses were performed on MAP values, since
these are most commonly used in comparing different
monitoring devices33 and also for guiding therapy. Compari-
son of systolic arterial pressure values may vary somewhat
from our results, although these were not reported for
conciseness.
Conclusion
This study shows that in a haemodynamically stable phase in
patients under general anaesthesia, the agreement with
invasive MAP measurements of Nexfin-derived MAPcNIAP was
found to be non-inferior to conventional MAPiNIAP measure-
ments. Although influence on outcome was not investigated,
this study demonstrates that MAPcNIAP has significant poten-
tial to improve patient monitoring in haemodynamically
stable patients undergoing anaesthesia where MAPiNIAP is at
present being clinically used.
Supplementary material
Supplementary material is available at British Journal of
Anaesthesia online.
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Influence of MAPinvasive on MAPcNIAP bias
0
Fig 4 Scatterplot showing the influence of the MAPinvasive value on MAPcNIAP accuracy. Values are shown for data points (n¼765) in the 30 min
measurement period with an interval of 5 min.
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